We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

3048:TSEBIC Cameras Inc. Analysis

Data as of 2026-06-04 - not real-time

¥1,790.00

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Technical outlook: The stock is trading just below a key resistance level while maintaining a bullish momentum signal from the MACD, which sits comfortably above its signal line and shows a positive histogram. Relative Strength Index is in the upper range, suggesting continued buying pressure but also warning of a potential overbought condition. The price sits above the short‑term and medium‑term moving averages, reinforcing the current bullish bias, and the beta reading is essentially neutral, indicating limited exposure to broader market swings. However, recent volume trends are tapering, and the 30‑day price volatility remains elevated, which adds a layer of short‑term uncertainty. Fundamental backdrop: Revenue growth remains modest but positive, and margins, while thin, are stable. Cash generation is strong, with operating and free cash flow comfortably covering dividend payouts, which sit at a respectable yield with a payout ratio well below the threshold of concern. The valuation sits near the discounted cash‑flow estimate, implying that the market price is roughly aligned with intrinsic expectations. The consumer‑cyclical nature of the business introduces sensitivity to economic cycles, yet the diversified product mix and steady dividend support a resilient long‑run profile.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • price approaching resistance with bullish MACD
  • elevated RSI indicating possible short‑term pullback
  • decreasing volume adding execution risk

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • valuation near fair value with upside potential
  • steady cash flow supporting dividend sustainability
  • moderate revenue growth and diversified product lineup

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • consistent dividend yield and reasonable payout ratio
  • low systematic risk reflected in neutral beta
  • strong balance sheet with ample cash relative to debt

Key Metrics & Analysis

Financial Health

Revenue Growth5.60%
Profit Margin1.95%
P/E Ratio15.7
ROE10.75%
ROA4.24%
Debt/Equity44.16
P/B Ratio1.7
Op. Cash Flow¥36.9B
Free Cash Flow¥20.9B

Technical Analysis

TrendBullish
RSI61.7
Support¥1,589.00
Resistance¥1,803.50
MA 20¥1,731.70
MA 50¥1,724.03
MA 200¥1,675.23
MACDBullish
VolumeDecreasing
Fear & Greed Index92.75

Valuation

Fair Value¥1,865.53
Target Price¥1,726.67
Upside/Downside-3.54%
GradeFair
TypeBlend
Dividend Yield2.40%

Risk Assessment

Beta-0.10
Volatility20.01%
Sector RiskMedium
Reg. RiskLow
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.